A Comprehensive Analysis Of Bhallatakadi Churna In The Management Of Amavata w.s.r To Rheumatoid Arthritis
DOI:
https://doi.org/10.48165/Keywords:
Amavata, Ama, Bhallatakadi Churna, Rheumatoid ArthritisAbstract
The Amavata of Ayurveda can be correlated with Rheumatoid Arthritis of contemporary medical science. Rheumatoid Arthritis is a chronic inflammatory systemic disorder triggered by auto-immunity to self-antigens. Its available modern management is still not satisfactory. Hence, majority of the patients are inclined towards the traditional systems of medicine including Ayurveda. Bhallatakadi Churna (comprises of 3 herbal drugs i.e.,
Bhallataka (Semecarpus anacardium Linn.), Tila (Sesamum indicum Linn.) & Haritaki (Terminalia chebula Retz.) is one of the promising herbal formulations, mentioned in Yogaratnakara for the management of Amavata (Rheumatoid Arthritis). It has capacity to alter basic matrix (Ama, Vata, Agnimandya) of diathesis of Amavata (Rheumatoid Arthritis). These drugs impart Deepana (appetizer), Rasayana (Rejuvenator), Anulomana (carminatives), Pachana (Digestive), Ama-doshahara, Medhya Prabhva (Nootropic) & Shothahara (anti-inflammatory) effect. So, this formulation used in Amavata (Rheumatoid Arthritis) not only pacify and correct the Ama & Vatadosha, but it also hit on the root cause of disease i.e., Mandagni (weak digestive fire). The critical evaluation of pharmacological actions of these drugs reveals its anti-oxidant, anti inflammatory, anti-nociceptive etc. effects, which is quite enough to modify the root cause of disease i.e., auto antigen (most correlative with Ama) and pacify the chief complaint of the patients of Rheumatoid Arthritis. In this article we will try put an emphasis on Bhallatakadi Churna by incorporating the classical and contemporary knowledge.
Downloads
References
Rakshit Vijay, Madhav nidana commentary , madhukosh teeka by madhavkara Amavata nidana chapter 25/1-5, Chaukhambha Prakashana, Varanasi, 2009.pg no. 508-09
Rakshit Vijay, Madhav nidana commentary , madhukosh teeka by madhavkara Amavata nidana chapter 25/1-5, Chaukhambha Prakashana, Varanasi, 2009.pg no. 509.
Shashtri Lakshmipati , Yogaratnakara with “Vidyotini” Hindi commentary, Pūrvārdha ,Chaukhambha Prakashana, Varanasi, 2010, p 567
Sharma PV. Dravyagunavijnan, Vol-II, Chapter 6, Varanasi, India: Publisher Chaukhambha Bharati Academy, reprint 2011, p166-168
Ayurvedic Pharmacopoeia of India, Published by Ministry of Health &Family Welfare , Edition 1,Year of publication 2003, part 1, Vol II, p19-20.
Kirtikar, K.R, Indian Medicinal Plants. Vol.1 L.M. Basu, Allahabad, 1933, pp-667.
S.Prasad ,Pharmacognostical studies on the fruit of Bhilawa (Semecrpus anacerdium) J. Res. Indian Med, 2(2) 1968: 222-224.
Mathur HN, Agarwal JS. Phenolic modified resin of oil varnishes. J Sci Indian Res. 1953; 12:411.
Rao NS, Row LR, Brown RT. Phenolic constituents of Semecarpus anacardium. Phytochemistry. 1973; 12:671–81.
Govindachary TR, Joshi BS, Kamal VM. Phenolic constituents of Semecarpus anacardium. Indian J Chem. 1971; 9:1044.
Indap MA, Ambaye RY, Gokhale SV. Anti tumour and pharmacological effect of oil from Semecarpus anacardium Linn.f. Indian J Physiol Pharmacol. 1983;27:83–91. [PubMed]
Rahman KM, Rahman MS, Begum Rashid B. Preliminary cytotoxicity screening of some medicinal plants of Bangladesh, Dhaka Univ. J Pharm Sci. 2008;7:47–52.
Sharma A, Mathur R, Dixit VP. Hypocholesterolemic activity of nut shell extract of Semecarpus anacardium (Bhilawa) in cholesterol fed rabbits. Indian J Exp Biol. 1995; 33:444–8. [PubMed]
Review article.
Selvam C, Jachak SM. A cyclooxygenase (COX) inhibitory biflavonoid from the seeds of Semecarpus anacardium. J Ethnopharmacol. 2004;95:209–12. [PubMed]
Bhitre MJ, Patil S, Kataria M, Anwikar S, Kadri H. Anti-inflammatory activity of the fruits of Semecarpus anacardium Linn. Asian J Chem. 2008; 2047–2050.
Verma N, Vinayak M. emecarpus anacardium Linn.: A review, Pharmagonosy Review , 2010 Jan-Jun; 4(7): pp- 88–94 [PubMed]
Farooq SM, A study on CNS effect of nut milk extract of Semicarpus anacardium. Pharmacologyonline. 2007; 1:49– 63.
Mohanta TK, Evaluation of antimicrobial activity and phytochemical screening of oils and nuts of Semecarpus anacardium. Sci Res Essay. 2007; 2:486–90.
Arul B, Kothai R, Christina AJ. Hypoglycemic and antihyperglycemic effect of Semecarpus anacardium Linn in normal and streptozotocin induced diabetic rats. Methods Find Exp Clin Pharmacol. 2004; 26:759–62. [PubMed]
Sugapriya D, Shanthi P, Sachdanandam P. Restoration of energy metabolism in leukemic mice treated by a siddha drug: Semecarpus anacardium Linn.nut milk extract. Chem Biol Interact. 2008; 173:43–58. [PubMed]
Sharma PV. Dravyagunavijnan, Vol-II, Chapter 6, Varanasi, India: Publisher Chaukhambha Bharati Academy, reprint 2011,pp-120-123
Ayurvedic Pharmacopoeia of India, Published by Ministry of Health &Family Welfare , Edition 1,Year of publication 2003, part 1, Vol.IV, p143-145
FULLER, D.Q. 2003. Further evidence on the prehistory of sesame. Asian Agri History 2003. 7(2): 127-137.
Milder, Ivon E. J.; (2005). "Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol". British Journal of Nutrition, (2005), 93 (3): 393–402.
Kuo PC, Lin MC, Chen GF, Yiu TJ, Tzen JT ,"Identification of methanol-soluble compounds in sesame and evaluation of antioxidant potential of its lignans”, J Agric Food Chem. 2011: 59 (7): 3214- 3219.
Monteiro EM, Chibli LA, Yamamoto CH, Pereira MC, Vilela FM, Rodarte MP, et al. Antinociceptive and anti-inflammatory activities of the sesame oil and sesamin. Nutrients. 2014;6(5):1931–1944
“Krishna tila”. International Ayurvedic Medical Journal Volume 3; Issue 11; November- 2015: ISSN: 2320 5091.
Saleem T.S. Mohammad, Anti-microbial activity of sesame oil. Int. J. Res. Phytochem. Pharmacol. 2011 :1(1), 21-23
Sharma PV. Dravyagunavijnan, Vol-II, Chapter 6, Varanasi, India: Publisher Chaukhambha Bharati Academy, reprint 2011 p753-758
Ayurvedic Pharmacopoeia of India, Published by Ministry of Health &Family Welfare , Edition 1,Year of publication 2003, part 1, Vol II, pp-62-63
Juang LJ, Sheu SJ, Lin TC. Oral Administration of Ethyl Acetate-Soluble Portion of Terminalia chebula Conferring Protection from Streptozotocin-Induced Diabetic Mellitus and Its Complications, J.Sep. Sci. 2004, 27, 718- 724.
Han Q, Song J, Qiao C, Wong L, Xu H. A COMPREHENSIVE BIOLOGICAL, ETHNO PHARMACOLOGICAL and PHYTOCHEMICAL UPDATE REVIEW ON AYURVEDIC PLANT OF TERMINALIA CHEBULA J.Sep. Sci. 2006, 29, 1653-165
Anil Mahajan, Nandini Pai, Simultaneous isolation and identification of phytoconstituents from Terminalia chebula by preparative chromatography, J. Chem. Pharm. Res., 2010, 2(5):97-103
Kannan P. Ramadevi S.R. and Waheeta Hopper. Antibacterial activity of Terminalia chebula fruit extract. African Journal of Microbiology Research , 2009Vol. 3 (4) pp. 180-184
Murali YK, Anand P, Tandon V, Singh R, Chandra R, Murthy PS. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats. Exp Clin Endocrinol Diabetes 2007; 115(10): 641-646 PMID: 18058598 [Pub Med - indexed for MEDLINE]
Anurag Singh, Ragini Srivastav, Ajai Kumar Pandey. Effect of the seeds of Terminalia chebula on blood serum, lipid profile and urine parameters in STZ induced Diabetic rats. J Pharmacogn Phytochem 2018;7(2):01-05.
Raju et al.: Evaluation of anti-ulcer activity of methanolic extract of Terminalia chebula fruits in experimental rats. J. Pharm. Sci. Res.,2009, 1 (3) pp. 101–107.
Sohni YR, Kaimal P, Bhatt RM. The antiamoebic effect of a crude drug formulation of herbal extracts against Entamoeba histolytica in vitro and in vivo. J Ethnopharmacol 1995; 45(1):43-52.
Sohni YR, Bhatt RM. Activity of a crude extract formulation in experimental hepatic amoebiasis and in immunomodulation studies. J Ethnopharmacol 1996; 54(2-3):119-24.
Cheng HW, Lin TC, Yu KH, Yang CM, Lin CC. Antioxidant and free radical Scavenging activities of Terminalia chebula. Biol Pharm Bull 2003;26(9):1331-35
Suchalatha S, Srinivasalu C, Devi S. Antioxidant activity of ethanolic extracts of Terminalia chebula fruit against isoproterenol induced oxidative stress in rats. Indian J Biochem and Biophys 2005 42:246-49
Hamada S et al. Immunosuppressive effects of gallic acid and chebulagic acid on CTL mediated cytotoxicity. Biological & Pharmaceutical Bulletin 1997; 20(9):1017-19.
Manosroi A et al. In vitro anti-aging activities of Terminalia chebula gall extract. Pharm Biol. 2010; 48(4):469-81.
Kr.Kushwaha, D., Sharma, D. A., & M.Porte, D. A Comparative Clinical study of Mritasanjivan Rasa and Sunthyadi Kwath in the management of Amavata with special reference to Dushivisa. International Research Journal of Ayurveda & Yoga, 2019: 2(5), 09-22.
Tasduq SS, Singh AK, Salti NK, Gupta DK, Suri K. Terminalia chebula fruits prevent liver toxicity caused by sub-chronic adminstration of refampicin, isoniazid and pyrazinamide (PZA) in combination. Hum Exp Toxicol. 2006; 25(3):11–18.
Singh Anurag, Srivastava Ragani, Pandey Ajai Kumar: Protective Role of Terminalia chebula in Streptozotocin-induced Diabetic Mice for Wound Healing Activity. British Journal of Medicine & Medical Research (BJMMR), 2017 : 22(2): 1-8.
